Presbyopia onset affects dynamic visual acuity via motor adaptation in naturalistic viewing conditions

Abstract

Purpose The present study investigated the effects of age on dynamic visual acuity (DVA) and its visuomotor correlates in a novel and naturalistic context, i.e. while consulting a smartphone during different mobility conditions. A hypothesis of an important role of presbyopia onset on DVA decline was tested, particularly focusing on the role of motor coordination as well as accommodation and vergence measures.

Methods Young and adult non-presbyopes, presbyopia-onset participants and aged presbyopes (n=63) carried out DVA tests on a smartphone while sitting, standing and walking. Eight vergence and accommodation measures as well as seven motor variables related to smartphone position in the head reference frame, were examined in relation to the DVA performance.

Results Age significantly affected DVA, with the most pronounced decline occurring at the onset of presbyopia. DVA decline with age was associated with visual accommodation, whereas vergence measures had minimal impact. Motor variables exerted an overall stronger impact on DVA with smartphone distance, antero-posterior and lateral movement of the smartphone as principal variables.

Conclusions The study shows that in daily visuo motor activities, presbyopia onset is associated with a strong decline in DVA, potentially caused by the lack of motor adaptation combined with age-related changes in accommodation during active mobility conditions. These results underscore the importance of sensory-motor adaptations in maintaining visual performance and suggest that uncorrected presbyopia or inadequate behavioral adjustments are important determinants of DVA decline during aging.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Essilor

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ile-de-France VII Personal Protection Committee

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Comments (0)

No login
gif